Login / Signup
Biswa Mohan Sahoo
ORCID
Publication Activity (10 Years)
Years Active: 2022-2023
Publications (10 Years): 2
Top Topics
Cardiovascular Disease
Replacement Therapy
Double Blind
Peritoneal Dialysis
Top Venues
Current drug research reviews
Reviews in endocrine & metabolic disorders
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Bimalendu Chowdhury
,
Biswa Mohan Sahoo
,
Akankshya Jena
,
K Hiramani
,
Amulyaratna Behera
,
Biswajeet Acharya
NOX-2 Inhibitors may be Potential Drug Candidates for the Management of COVID-19 Complications.
Current drug research reviews
(2023)
Manoj Kumar Mahapatra
,
Muthukumar Karuppasamy
,
Biswa Mohan Sahoo
Semaglutide, a glucagon like peptide-1 receptor agonist with cardiovascular benefits for management of type 2 diabetes.
Reviews in endocrine & metabolic disorders
23 (3) (2022)